Mathew Pletcher | Vice President, Head of Genomic Discovery
Autism Speaks

Mathew Pletcher, Vice President, Head of Genomic Discovery, Autism Speaks

Mathew Pletcher serves as Vice President, Head of Genomic Discovery for Autism Speaks.  As part of his role with Autism Speaks, he directs the Autism Genetic Resource Exchange (AGRE) and oversees MSSNG, a collaboration between Autism Speaks, Google, and the Hospital for Sick Children, to make available in an open-access database over 10,000 whole genome sequences from families with autism.  Mathew received a B.S. in biology from Duquesne University and a Ph.D. in human genetics from the Johns Hopkins School of Medicine.  He has held posts at the Genomics Institute of the Novartis Research Foundation, the Scripps Research Institute, and Pfizer Global Research and Development.  In his role as Director of Medical Genetics at Pfizer, he led drug development programs for progeria, lysosomal storage diseases, sickle cell disease, myotonic dystrophy and amyotrophic lateral sclerosis.  He has also founded the RDH12 Fund for Sight, a non-profit organization devoted to the development of a gene therapy for a genetic form of Leber Congenital Amaurosis, a congenital blinding disorder

back to speakers